Loading clinical trials...
Loading clinical trials...
Retinal Deep PhenotypingTM Platform for Cerebral Amyloid Status Evaluation: a Validation Study
Conditions
Locations
7
United States
Ezy Medical Research
Miami, Florida, United States
Lou Ruvo Center for Brain Health at Cleveland Clinic (LR-CC)
Las Vegas, Nevada, United States
East Virginia Medical School (EVMS)
Norfolk, Virginia, United States
University of Washington (MBWC)
Seattle, Washington, United States
Ottawa Memory Clinic (OMC)
Ottawa, Ontario, Canada
Centricity Research
Toronto, Ontario, Canada
Start Date
June 7, 2022
Primary Completion Date
July 25, 2024
Completion Date
July 25, 2024
Last Updated
August 7, 2024
NCT07545473
NCT07531732
NCT07101380
NCT07290387
NCT06657768
NCT07220668
Lead Sponsor
Optina Diagnostics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions